Allied Market Research

2024

Tissue Diagnostics Market

Tissue Diagnostics Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, by Disease, by Technology and by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Tissue diagnostics involves removal of tissue (at a micro level) from the patient’s body, which is then processed, analyzed, and tested under the microscope to detect diseases such as cancer. Advancements in the techniques and equipment of tissue diagnostics helps for fast and accurate determination and evaluation of diseases related to the tissues.

Rise in incidences of cancer, rapid increase in aging population, and growth in healthcare expenditure drive the market. However, budget constraints and high degree of consolidation restrain the market growth. In addition, emerging markets and increased use of personalized medicine offer lucrative opportunities for the market growth.

The report segments the tissue diagnostic market on the basis of product, disease, technology, end user, and region. Based on the product, the market is bifurcated into consumables and instruments. Based on diseases, it is classified into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and others. Based on technology, it is categorized into immunohistochemistry (IHC), situ hybridization (ISH), digital pathology & workflow management, and special staining. Based on end users, the market is divided into hospitals, research laboratories, pharmaceutical companies, contract research organizations, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players of tissue diagnostics market are Abbott Laboratories, Inc., Agilent Technologies, Inc., Biogenex Laboratories, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman-La Roche AG, Sakura Finetek Japan Co., Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific, and Bio Sb.

Key Benefits

  • The study provides an in-depth analysis of the tissue diagnostics market, with current trends and future estimations to elucidate the imminent investment pockets.
  • Extensive analysis of the market by product type elucidates various forms of tissue diagnostics market.
  • Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.
  • This report entails the detailed quantitative analysis of the current market trends and estimations which helps identify the prevailing market opportunities.

Tissue Diagnostics Market Report Highlights

Aspects Details
icon_5
By Product
  • Consumables
    • Antibodies
    • Kits
    • Reagents
    • Probes
  • Instruments
    • Slide staining systems
    • Scanners
    • Tissue processing system
    • Other instruments
icon_6
By Disease
  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-Small Cell Lung Cancer
  • Other Diseases
icon_7
By Technology
  • Immunohistochemistry (IHC)
  • In-Situ Hybridization (ISH)
  • Digital Pathology and Workflow Management
  • Special Staining
icon_8
By End User
  • Hospitals, Research Laboratories
  • Pharmaceutical Companies
  • Contract Research Organizations
icon_9
Key Market Players

Cell Signaling Technology, Inc., Abbott Laboratories, Inc., Biogenex Laboratories, Thermo Fisher Scientific, Bio Sb, Danaher Corporation, F. Hoffman-La Roche AG, Sigma-Aldrich Corporation, Sakura Finetek Japan Co., Ltd., Agilent Technologies, Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Tissue Diagnostics Market

Global Opportunity Analysis and Industry Forecast, 2023-2032